Cole A, Cosgrove Sweeney Y, Lasseter A, Gray J, Beavis A, Chong C, et al. Evaluation of the Pig-Tailed Macaque (Macaca nemestrina) as a Model of Human Staphylococcus aureus Nasal Carriage. Infect Immun. 2018;86: pubmed publisher

Cole A, Schmidt Owens M, Beavis A, Chong C, Tarwater P, SCHAUS J, et al. Cessation from Smoking Improves Innate Host Defense and Clearance of Experimentally Inoculated Nasal Staphylococcus aureus. Infect Immun. 2018;86: pubmed publisher

Mohammad H, Cushman M, Seleem M. Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model. PLoS ONE. 2015;10:e0142321 pubmed publisher

Davis M, Misic A, Morris D, Moss J, Tolomeo P, Beiting D, et al. Genome sequencing reveals strain dynamics of methicillin-resistant Staphylococcus aureus in the same household in the context of clinical disease in a person and a dog. Vet Microbiol. 2015;180:304-7 pubmed publisher

Youn S, Lee S, Kim S, Lee J, Kim B, Kim J, et al. Drug utilization review of mupirocin ointment in a Korean university-affiliated hospital. Korean J Intern Med. 2015;30:515-20 pubmed publisher

Pedersen J, Pedersen J, Otzen D. The Use of Liprotides To Stabilize and Transport Hydrophobic Molecules. Biochemistry. 2015;54:4815-23 pubmed publisher

Kohler P, Sommerstein R, Schönrath F, Ajdler Schäffler E, Anagnostopoulos A, Tschirky S, et al. Effect of perioperative mupirocin and antiseptic body wash on infection rate and causative pathogens in patients undergoing cardiac surgery. Am J Infect Control. 2015;43:e33-8 pubmed publisher

Goh S, Hohmeier A, Stone T, Offord V, Sarabia F, García Ruiz C, et al. Silencing of Essential Genes within a Highly Coordinated Operon in Escherichia coli. Appl Environ Microbiol. 2015;81:5650-9 pubmed publisher

Estrada Leypon O, Moya A, Guimera A, Gabriel G, Agut M, Sanchez B, et al. Simultaneous monitoring of Staphylococcus aureus growth in a multi-parametric microfluidic platform using microscopy and impedance spectroscopy. Bioelectrochemistry. 2015;105:56-64 pubmed publisher

Barrett E, Deshpandey A, Ryan C, Dempsey E, Murphy B, O Sullivan L, et al. The neonatal gut harbours distinct bifidobacterial strains. Arch Dis Child Fetal Neonatal Ed. 2015;100:F405-10 pubmed publisher

Baratz M, Hallmark R, Odum S, Springer B. Twenty Percent of Patients May Remain Colonized With Methicillin-resistant Staphylococcus aureus Despite a Decolonization Protocol in Patients Undergoing Elective Total Joint Arthroplasty. Clin Orthop Relat Res. 2015;473:2283-90 pubmed publisher

Musilova S, Rada V, Marounek M, Nevoral J, Dusková D, Bunesova V, et al. Prebiotic effects of a novel combination of galactooligosaccharides and maltodextrins. J Med Food. 2015;18:685-9 pubmed publisher

Čitar M, Hacin B, Tompa G, Stempelj M, Rogelj I, Dolinsek J, et al. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells. Benef Microbes. 2015;6:325-36 pubmed publisher

Campbell D, Johnson D, Mudge D, Gallagher M, Craig J. Prevention of peritoneal dialysis-related infections. Nephrol Dial Transplant. 2015;30:1461-72 pubmed publisher

Dorrani M, Kaul M, Parhi A, LaVoie E, Pilch D, Michniak Kohn B. TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin. Int J Pharm. 2014;476:199-204 pubmed publisher

Seth A, Zhong A, Nguyen K, Hong S, Leung K, Galiano R, et al. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model. Wound Repair Regen. 2014;22:712-9 pubmed publisher

Feiszt P, Mestyán G, Kerényi M, Dobay O, Szabó J, Dombrádi Z, et al. Re-evaluation of in vitro activity of primycin against prevalent multiresistant bacteria. Int J Med Microbiol. 2014;304:1077-85 pubmed publisher

Lee A, Gizard Y, Empel J, Bonetti E, Harbarth S, François P. Mupirocin-induced mutations in ileS in various genetic backgrounds of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2014;52:3749-54 pubmed publisher

Bai N, Chen Y, Fu Y, Wu P, Zhang W. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients. J Clin Pharm Ther. 2014;39:521-6 pubmed publisher

Choi J, Lee J, Park K, Kim B, Yeo U, Huh C, et al. A retrospective analysis of the clinical efficacies of Q-switched Alexandrite and Q-switched Nd:YAG lasers in the treatment of nevus of Ota in Korean patients. J Dermatolog Treat. 2015;26:240-5 pubmed publisher

Haisma E, de Breij A, Chan H, van Dissel J, Drijfhout J, Hiemstra P, et al. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents. Antimicrob Agents Chemother. 2014;58:4411-9 pubmed publisher

Schlett C, Millar E, Crawford K, Cui T, Lanier J, Tribble D, et al. Prevalence of chlorhexidine-resistant methicillin-resistant Staphylococcus aureus following prolonged exposure. Antimicrob Agents Chemother. 2014;58:4404-10 pubmed publisher

Wisniewska K, Piorkowska A, Kasprzyk J, Bronk M, Swieć K. Clonal distribution of bone sialoprotein-binding protein gene among Staphylococcus aureus isolates associated with bloodstream infections. Folia Microbiol (Praha). 2014;59:465-71 pubmed publisher

Perera V, Newton G, Parnell J, Komives E, Pogliano K. Purification and characterization of the Staphylococcus aureus bacillithiol transferase BstA. Biochim Biophys Acta. 2014;1840:2851-61 pubmed publisher

Neri I, Montanari F, Baraldi C, Ricci L, Patrizi A. Erysipelas as a superinfection of an oral lymphangioma. J Pediatr. 2014;165:205-205.e1 pubmed publisher

Jaspers M, Breederveld R, Tuinebreijer W, Diederen B. The evaluation of nasal mupirocin to prevent Staphylococcus aureus burn wound colonization in routine clinical practice. Burns. 2014;40:1570-4 pubmed publisher

Power A, Hill P, Singh S, Ashby D, Taube D, Duncan N. Comparison of Tesio and LifeCath twin permanent hemodialysis catheters: the VyTes randomized trial. J Vasc Access. 2014;15:108-15 pubmed publisher

Camus C, Salomon S, Bouchigny C, Gacouin A, Lavoue S, Donnio P, et al. Short-term decline in all-cause acquired infections with the routine use of a decontamination regimen combining topical polymyxin, tobramycin, and amphotericin B with mupirocin and chlorhexidine in the ICU: a single-center experience. Crit Care Med. 2014;42:1121-30 pubmed publisher

Sastre A, Roberts P, Presutti R. A practical guide to community-acquired MRSA. J Fam Pract. 2013;62:624-9 pubmed

Hetem D, Bonten M. Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect. 2013;85:249-56 pubmed publisher

Johnson D, Badve S, Pascoe E, Beller E, Cass A, Clark C, et al. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. Lancet Infect Dis. 2014;14:23-30 pubmed publisher

Arpey C. A preoperative approach to postoperative infections?. Dermatol Surg. 2013;39:1494-5 pubmed publisher

Cherian P, Gunson T, Borchard K, Tai Y, Smith H, Vinciullo C. Oral antibiotics versus topical decolonization to prevent surgical site infection after Mohs micrographic surgery--a randomized, controlled trial. Dermatol Surg. 2013;39:1486-93 pubmed publisher

Parvizi J. CORR Insights®: Staphylococcus aureus colonization among arthroplasty patients previously treated by decolonization protocol: a pilot study. Clin Orthop Relat Res. 2013;471:3133-4 pubmed publisher

. Screening for MRSA and isolating carriers doesn't reduce ICU infections. BMJ. 2013;346:f3581 pubmed publisher

Huang S, Septimus E, Kleinman K, Moody J, Hickok J, Avery T, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368:2255-65 pubmed publisher

Park S, Kim S, Lee J, Park C, Lee D. Community-genotype strains of methicillin-resistant Staphylococcus aureus with high-level mupirocin resistance in a neonatal intensive care unit. Early Hum Dev. 2013;89:661-5 pubmed publisher

Economedes D, Deirmengian G, Deirmengian C. Staphylococcus aureus colonization among arthroplasty patients previously treated by a decolonization protocol: a pilot study. Clin Orthop Relat Res. 2013;471:3128-32 pubmed publisher

Mehta S, Hadley S, Hutzler L, Slover J, Phillips M, Bosco J. Impact of preoperative MRSA screening and decolonization on hospital-acquired MRSA burden. Clin Orthop Relat Res. 2013;471:2367-71 pubmed publisher

Lepainteur M, Royer G, Bourrel A, Romain O, Duport C, Doucet Populaire F, et al. Prevalence of resistance to antiseptics and mupirocin among invasive coagulase-negative staphylococci from very preterm neonates in NICU: the creeping threat?. J Hosp Infect. 2013;83:333-6 pubmed publisher

Hwang P. Staph aureus has long been recognized as being more prevalent in cultures from patients with chronic rhinosinusitis(CRS) compared to those with acute rhinosinusitis. Int Forum Allergy Rhinol. 2013;3:81-2 pubmed publisher

Engelhard E, Spanjaard L, Stijnis C. [Treatment of recurrent furunculosis]. Ned Tijdschr Geneeskd. 2013;157:A5548 pubmed

Lee H, Lim H, Bae I, Yong D, Jeong S, Lee K, et al. Coexistence of mupirocin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates from Korea. Diagn Microbiol Infect Dis. 2013;75:308-12 pubmed publisher

García Lozano T, Egido A, Contel E, Picón M, Martínez M, Aznar E. [Is it necessary to know which workers are carriers of MRSA in contact with cancer patients?]. Rev Esp Quimioter. 2012;25:252-5 pubmed

Chiu Y, Lin C, Lin C, Hsu K, Chang L, Yang J. Space-related pharma-motifs for fast search of protein binding motifs and polypharmacological targets. BMC Genomics. 2012;13 Suppl 7:S21 pubmed publisher

Matanović K, Pérez Roth E, Pintaric S, Seol Martinec B. Molecular characterization of high-level mupirocin resistance in Staphylococcus pseudintermedius. J Clin Microbiol. 2013;51:1005-7 pubmed publisher

Smith C, Goldman R. Staphylococcus aureus decolonization for recurrent skin and soft tissue infections in children. Can Fam Physician. 2012;58:1350-2 pubmed

Canpolat F, Erkocoglu M, Tezer H, Kocabas C, Kandi B. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial. Eur Rev Med Pharmacol Sci. 2012;16:1989-93 pubmed

Guo Y, Ramos R, Cho J, Donegan N, Cheung A, Miller L. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Antimicrob Agents Chemother. 2013;57:855-63 pubmed publisher

Seiberling K, Aruni W, Kim S, Scapa V, FLETCHER H, Church C. The effect of intraoperative mupirocin irrigation on Staphylococcus aureus within the maxillary sinus. Int Forum Allergy Rhinol. 2013;3:94-8 pubmed publisher

Fritz S, Hogan P, Camins B, Ainsworth A, Patrick C, Martin M, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother. 2013;57:559-68 pubmed publisher

McDanel J, Murphy C, Diekema D, Quan V, Kim D, Peterson E, et al. Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother. 2013;57:552-8 pubmed publisher

Ryder V, Chopra I, O Neill A. Increased mutability of Staphylococci in biofilms as a consequence of oxidative stress. PLoS ONE. 2012;7:e47695 pubmed publisher

Crepinsek M, Crowe L, Michener K, Smart N. Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev. 2012;10:CD007239 pubmed publisher

Van Rijen M, Bode L, Baak D, Kluytmans J, Vos M. Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaedic surgery. PLoS ONE. 2012;7:e43065 pubmed publisher

Shuman A, Shuman E, Hauff S, Fernandes L, Light E, Chenoweth C, et al. Preoperative topical antimicrobial decolonization in head and neck surgery. Laryngoscope. 2012;122:2454-60 pubmed publisher

Jervis Bardy J, Boase S, Psaltis A, Foreman A, Wormald P. A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. Laryngoscope. 2012;122:2148-53 pubmed publisher

Abimanyu N, Murugesan S, Krishnan P. Emergence of methicillin-resistant Staphylococcus aureus ST239 with high-level mupirocin and inducible clindamycin resistance in a tertiary care center in Chennai, South India. J Clin Microbiol. 2012;50:3412-3 pubmed publisher

Choudhury S, Krishnan P, Ang B. Prevalence of high-level mupirocin resistance among meticillin-resistant Staphylococcus aureus isolates in a tertiary care hospital in Singapore. J Hosp Infect. 2012;82:56-7 pubmed publisher

Weir S, Fram J, Berg G, Kabbani D, Strymish J, Tang M, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from patients newly identified as nasal carriers. J Clin Microbiol. 2012;50:3283-6 pubmed publisher

Kohler P, Bregenzer Witteck A, Rettenmund G, Otterbech S, Schlegel M. MRSA decolonization: success rate, risk factors for failure and optimal duration of follow-up. Infection. 2013;41:33-40 pubmed publisher

Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol. 2011;7:e1002310 pubmed publisher

Vondenhoff G, Van Aerschot A. Aminoacyl-tRNA synthetase inhibitors as potential antibiotics. Eur J Med Chem. 2011;46:5227-36 pubmed publisher

Gutierrez Lugo M, Bewley C. Susceptibility and mode of binding of the Mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to tRNA synthetase inhibitors. Bioorg Med Chem Lett. 2011;21:2480-3 pubmed publisher

Gurney R, Thomas C. Mupirocin: biosynthesis, special features and applications of an antibiotic from a gram-negative bacterium. Appl Microbiol Biotechnol. 2011;90:11-21 pubmed publisher

Joo H, Chan J, Cheung G, Otto M. Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aure. Antimicrob Agents Chemother. 2010;54:4942-4 pubmed publisher

Vaara M, Siikanen O, Apajalahti J, Fox J, Frimodt Møller N, He H, et al. A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. Antimicrob Agents Chemother. 2010;54:3341-6 pubmed publisher

Pérez Roth E, Kwong S, Alcoba Florez J, Firth N, Mendez Alvarez S. Complete nucleotide sequence and comparative analysis of pPR9, a 41.7-kilobase conjugative staphylococcal multiresistance plasmid conferring high-level mupirocin resistance. Antimicrob Agents Chemother. 2010;54:2252-7 pubmed publisher

Thomas C, Hothersall J, Willis C, Simpson T. Resistance to and synthesis of the antibiotic mupirocin. Nat Rev Microbiol. 2010;8:281-9 pubmed publisher

Xu G, Tu W, Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant. 2010;25:587-92 pubmed publisher

Patel J, Gorwitz R, Jernigan J. Mupirocin resistance. Clin Infect Dis. 2009;49:935-41 pubmed publisher

Hurdle J, Yendapally R, Sun D, Lee R. Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections. Antimicrob Agents Chemother. 2009;53:4028-31 pubmed publisher

Coates T, Bax R, Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother. 2009;64:9-15 pubmed publisher

Van de Vijver P, Vondenhoff G, Denivelle S, Rozenski J, Verhaegen J, Van Aerschot A, et al. Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines. Bioorg Med Chem. 2009;17:260-9 pubmed publisher

Czaplewski L, Collins I, Boyd E, Brown D, East S, Gardiner M, et al. Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ. Bioorg Med Chem Lett. 2009;19:524-7 pubmed publisher

van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev. 2008;:CD006216 pubmed publisher

Gentry D, McCloskey L, Gwynn M, Rittenhouse S, Scangarella N, Shawar R, et al. Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus. Antimicrob Agents Chemother. 2008;52:4507-9 pubmed publisher

Traczewski M, Brown S. Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent. Antimicrob Agents Chemother. 2008;52:3863-7 pubmed publisher

Vaara M, Fox J, Loidl G, Siikanen O, Apajalahti J, Hansen F, et al. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. Antimicrob Agents Chemother. 2008;52:3229-36 pubmed publisher

Van de Vijver P, Ostrowski T, Sproat B, Goebels J, Rutgeerts O, Van Aerschot A, et al. Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants. J Med Chem. 2008;51:3020-9 pubmed publisher

Farhanullah -, Kang T, Yoon E, Choi E, Kim S, Lee J. 2-[2-Substituted-3-(3,4-dichlorobenzylamino)propylamino]-1H-quinolin-4-ones as Staphylococcus aureus methionyl-tRNA synthetase inhibitors. Eur J Med Chem. 2009;44:239-50 pubmed publisher

Mendes R, Deshpande L, Castanheira M, DiPersio J, Saubolle M, Jones R. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother. 2008;52:2244-6 pubmed publisher

Van Rijen M, Bonten M, Wenzel R, Kluytmans J. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother. 2008;61:254-61 pubmed publisher

Trautmann M, Stecher J, Hemmer W, Luz K, Panknin H. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies. Chemotherapy. 2008;54:9-16 pubmed

Simor A, Stuart T, Louie L, Watt C, Ofner Agostini M, Gravel D, et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother. 2007;51:3880-6 pubmed

Meehl M, Herbert S, Götz F, Cheung A. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51:2679-89 pubmed

Driscoll D, Young C, Ochsner U. Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism. Antimicrob Agents Chemother. 2007;51:2247-8 pubmed

Paulander W, Pennhag A, Andersson D, Maisnier Patin S. Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother. 2007;51:766-9 pubmed

Hu J, Garo E, Hough G, Goering M, O Neil Johnson M, Eldridge G. Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens. J Nat Prod. 2006;69:585-90 pubmed

Kallen A, Wilson C, Larson R. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol. 2005;26:916-22 pubmed

. The CARI guidelines. Evidence for peritonitis treatment and prophylaxis: prophylaxis for exit site/tunnel infections using mupirocin. Nephrology (Carlton). 2004;9 Suppl 3:S86-90 pubmed

Laupland K, Conly J. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis. 2003;37:933-8 pubmed

Kikuchi K. [Mupirocin resistant MRSA in Japan]. Nihon Rinsho. 2001;59:724-7 pubmed

Henkel T, Finlay J. Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?. J Chemother. 1999;11:331-7 pubmed

Williford P. Opportunities for mupirocin calcium cream in the emergency department. J Emerg Med. 1999;17:213-20 pubmed

Mehtar S. New strategies for the use of mupirocin for the prevention of serious infection. J Hosp Infect. 1998;40 Suppl B:S39-44 pubmed

Cookson B. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother. 1998;41:11-8 pubmed

Bertino J. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus. Am J Health Syst Pharm. 1997;54:2185-91 pubmed

Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect. 1997;35:1-8 pubmed

Poupard J. Update on mupirocin resistance. J Chemother. 1995;7 Suppl 3:71-4 pubmed